American Association for Cancer Research® (AACR) Annual Meeting 2024 Posters

87

Integrated Pipeline for Immuno-Oncology Drug Testing: From Patient-Derived Organoid Assays with Reconstituted TME to Fresh Ex Vivo Patient Tissue Cultures

538

Establishment of PARP Inhibitor-Induced Resistant Patient-Derived Ovarian Cancer Xenograft Models

1942

Developing KRAS G12C Inhibitor-Resistant Tumor Models for Efficacy Evaluation of Next-Generation Anticancer Therapies

2827

Characterization of Acute Myeloid Leukemia PDX Models with Hotspot Gene Mutations for Therapeutic Evaluation

3515

SynAI: An AI-Driven Cancer Drug Synergism Prediction Platform

Session Category: Bioinformatics / Computational Biology / Systems Biology / Convergent ScienceA
Authors: Kuan Yan

4179

Magnetic Resonance Imaging and Bioluminescence Imaging for Evaluating Tumor Burden in Orthotopic Glioblastoma

4213

Multiplex Digital Spatial Profiling of Proteins and RNA in MC38 Mouse Colorectal Cancer Syngeneic Model

5264

KRASG12C Inhibition Synergizes with Checkpoint Blockade in KRASG12C-Mutated Tumor Model

Session Category: Immunology
Authors: Aaron Li Hua

7174

Pharmacokinetics and Immunogenicity of Anti-PD-1 Antibody in Humanized FcRn Mouse Models Compared to Immunocompetent Mouse Models

LB435

Large Panel Organoid Drug Testing Combined with Biomarker Analysis: Unveiling Prospects of Mechanism of Action Identification and Preclinical Patient Stratification